Effects of chronic treatment with escitalopram or citalopram on extracellular 5‐HT in the prefrontal cortex of rats: role of 5‐HT1A receptors
Open accessThe DOI matches its Crossref record.
Abstract
Microdialysis was used to study the acute and chronic effects of escitalopram (S‐citalopram; ESCIT) and chronic citalopram (CIT), together with the 5‐HT 1A receptor antagonist WAY100,635 (N‐[2‐[methoxyphenyl)‐1‐piperazinyl]ethyl]‐N‐(2‐pyridinyl) cyclohexane carboxamide trihydrochloride) and the 5‐HT 1A receptor agonist 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin (8‐OH‐DPAT), on extracellular 5‐hydroxytryptamine (5‐HT) levels in the rat prefrontal cortex. Extracellular 5‐HT rose to 234 and 298% of basal values after subcutaneous (s.c.) acute doses of 0.15 and 0.63 mg kg−1 ESCIT. No further increase was observed at 2.5 mg kg−1 ESCIT (290%). The effect of 13‐day s.c. infusion of 10 mg kg−1 day−1 ESCIT on extracellular 5‐HT (422% of baseline) was greater than after 2 days (257% of baseline), whereas exposure to ESCIT was similar. In contrast, the increase in extracellular 5‐HT induced by the infusion of CIT for 2 (306%) and 13 days (302%) was similar. However, brain and plasma levels of S‐citalopram in rats infused with CIT for 13 days were lower than after 2 days. Acute treatment with 2.5 mg kg−1 ESCIT or 5 mg kg−1 CIT raised extracellular 5‐HT by 243 and 276%, respectively, in rats given chronic vehicle but had no effect in rats given ESCIT (10 mg kg−1 day−1) or CIT (20 mg kg−1 day−1) for 2 or 13 days, suggesting that the infused doses had maximally increased extracellular 5‐HT. WAY100,635 (0.1 mg kg−1 s.c.) increased extracellular 5‐HT levels by 168, 174 and 169% of prechallenge values in rats infused with vehicle or ESCIT for 2 or 13 days, respectively. WAY100,635 enhanced extracellular 5‐HT levels to 226, 153 and 164% of prechallenge values in rats infused with vehicle or CIT for 2 and 13 days, respectively. 8‐OH‐DPAT (0.025 mg kg−1) reduced extracellular 5‐HT by 54% in control rats, but had no effect in those given ESCIT and CIT for 13 days. This series of experiments led to the conclusion that chronic treatment with ESCIT desensitizes the 5‐HT 1A receptors, regulating the release of 5‐HT in the prefrontal cortex and enhances the effect of the drug on extracellular 5‐HT. They also indicate that chronic treatment with ESCIT and CIT did not prevent WAY100,635 from raising extracellular 5‐HT. British Journal of Pharmacology (2004) 142, 469–478. doi:10.1038/sj.bjp.0705800
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Manta, S., El Mansari, M., Debonnel, G., & Blier, P. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000387 · Cited by 192
“In the PFC, in contrast to chronic administration of SSRIs, which have been shown many times to increase cortical extracellular 5-HT levels (Bel & Artigas, 1993 ; Ceglia et al. 2004; Tanda et al. 1996b), long-term VNS had no effect on 5-HT levels in that area.”
ResultBianchi, P., Ciani, E., Guidi, S., Trazzi, S., Felice, D., Grossi, G., Fernandez, M., Giuliani, A., Calza, L., & Bartesaghi, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0534-10.2010 · Cited by 188
“This is in line with evidence showing that, although SSRIs increase extracellular levels of 5-HT (Ceglia et al., 2004), they concomitantly reduce brain levels of 5-HT, due to suppression of 5-HT synthesis (Trouvin et al.”
ResultRenoir, T. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00045 · Cited by 107
Brown, H. D., Amodeo, D. A., Sweeney, J. A., & Ragozzino, M. E. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111430749 · Cited by 56
Escitalopram: A Review of its Use in the Management of Anxiety Disorders
Dhillon, S., Scott, L. J., & Plosker, G. L. (2006) · CNS Drugs · doi:10.2165/00023210-200620090-00010 · Cited by 47
Metadata
- Authors
- Ceglia, I., Acconcia, S., Fracasso, C., Colovic, M., Caccia, S., & Invernizzi, R. W.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2004-06
- Volume
- 142
- Issue
- 3
- Pages
- 469-478
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2010514643
- Cited by
- 95
- References
- 0
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of chronic treatment with escitalopram or citalopram on extracellular 5‐HT in the prefrontal cortex of rats: role of 5‐HT1A receptors. https://app.cochat.ai/papers/10.1038/sj.bjp.0705800
- The paper
- Ceglia, I., Acconcia, S., Fracasso, C., Colovic, M., Caccia, S., & Invernizzi, R. W. (2004). Effects of chronic treatment with escitalopram or citalopram on extracellular 5‐HT in the prefrontal cortex of rats: role of 5‐HT1A receptors. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705800
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.